800 related articles for article (PubMed ID: 25668262)
1. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.
; Kieburtz K; Tilley BC; Elm JJ; Babcock D; Hauser R; Ross GW; Augustine AH; Augustine EU; Aminoff MJ; Bodis-Wollner IG; Boyd J; Cambi F; Chou K; Christine CW; Cines M; Dahodwala N; Derwent L; Dewey RB; Hawthorne K; Houghton DJ; Kamp C; Leehey M; Lew MF; Liang GS; Luo ST; Mari Z; Morgan JC; Parashos S; Pérez A; Petrovitch H; Rajan S; Reichwein S; Roth JT; Schneider JS; Shannon KM; Simon DK; Simuni T; Singer C; Sudarsky L; Tanner CM; Umeh CC; Williams K; Wills AM
JAMA; 2015 Feb; 313(6):584-93. PubMed ID: 25668262
[TBL] [Abstract][Full Text] [Related]
2. Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.
Wills AM; Li R; Pérez A; Ren X; Boyd J;
J Neurol; 2017 Aug; 264(8):1746-1753. PubMed ID: 28712000
[TBL] [Abstract][Full Text] [Related]
3. Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.
Elm JJ;
Mov Disord; 2012 Oct; 27(12):1513-21. PubMed ID: 23079770
[TBL] [Abstract][Full Text] [Related]
4. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
[TBL] [Abstract][Full Text] [Related]
5. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
; Schwarzschild MA; Ascherio A; Casaceli C; Curhan GC; Fitzgerald R; Kamp C; Lungu C; Macklin EA; Marek K; Mozaffarian D; Oakes D; Rudolph A; Shoulson I; Videnovic A; Scott B; Gauger L; Aldred J; Bixby M; Ciccarello J; Gunzler SA; Henchcliffe C; Brodsky M; Keith K; Hauser RA; Goetz C; LeDoux MS; Hinson V; Kumar R; Espay AJ; Jimenez-Shahed J; Hunter C; Christine C; Daley A; Leehey M; de Marcaida JA; Friedman JH; Hung A; Bwala G; Litvan I; Simon DK; Simuni T; Poon C; Schiess MC; Chou K; Park A; Bhatti D; Peterson C; Criswell SR; Rosenthal L; Durphy J; Shill HA; Mehta SH; Ahmed A; Deik AF; Fang JY; Stover N; Zhang L; Dewey RB; Gerald A; Boyd JT; Houston E; Suski V; Mosovsky S; Cloud L; Shah BB; Saint-Hilaire M; James R; Zauber SE; Reich S; Shprecher D; Pahwa R; Langhammer A; LaFaver K; LeWitt PA; Kaminski P; Goudreau J; Russell D; Houghton DJ; Laroche A; Thomas K; McGraw M; Mari Z; Serrano C; Blindauer K; Rabin M; Kurlan R; Morgan JC; Soileau M; Ainslie M; Bodis-Wollner I; Schneider RB; Waters C; Ratel AS; Beck CA; Bolger P; Callahan KF; Crotty GF; Klements D; Kostrzebski M; McMahon GM; Pothier L; Waikar SS; Lang A; Mestre T
JAMA; 2021 Sep; 326(10):926-939. PubMed ID: 34519802
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Parkinson Study Group CALM Cohort Investigators
Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
[TBL] [Abstract][Full Text] [Related]
7. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
Parashos SA; Luo S; Biglan KM; Bodis-Wollner I; He B; Liang GS; Ross GW; Tilley BC; Shulman LM;
JAMA Neurol; 2014 Jun; 71(6):710-6. PubMed ID: 24711047
[TBL] [Abstract][Full Text] [Related]
8. Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
Leehey M; Luo S; Sharma S; Wills AA; Bainbridge JL; Wong PS; Simon DK; Schneider J; Zhang Y; Pérez A; Dhall R; Christine CW; Singer C; Cambi F; Boyd JT
Neurology; 2017 Oct; 89(17):1789-1794. PubMed ID: 28972194
[TBL] [Abstract][Full Text] [Related]
9. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.
Pahwa R; Tanner CM; Hauser RA; Isaacson SH; Nausieda PA; Truong DD; Agarwal P; Hull KL; Lyons KE; Johnson R; Stempien MJ
JAMA Neurol; 2017 Aug; 74(8):941-949. PubMed ID: 28604926
[TBL] [Abstract][Full Text] [Related]
10. Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.
Hauser RA; Stocchi F; Rascol O; Huyck SB; Capece R; Ho TW; Sklar P; Lines C; Michelson D; Hewitt D
JAMA Neurol; 2015 Dec; 72(12):1491-500. PubMed ID: 26523919
[TBL] [Abstract][Full Text] [Related]
11. Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial.
Parkinson Study Group STEADY-PD III Investigators
Ann Intern Med; 2020 May; 172(9):591-598. PubMed ID: 32227247
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
NINDS NET-PD Investigators
Neurology; 2006 Mar; 66(5):664-71. PubMed ID: 16481597
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial.
Stevens KN; Creanor S; Jeffery A; Whone A; Zajicek J; Foggo A; Jones B; Chapman R; Cocking L; Wilks J; Webb D; Carroll C;
JAMA Neurol; 2022 Dec; 79(12):1232-1241. PubMed ID: 36315128
[TBL] [Abstract][Full Text] [Related]
14. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
Fahn S;
J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort.
Bega D; Kim S; Zhang Y; Elm J; Schneider J; Hauser R; Fraser A; Simuni T
J Parkinsons Dis; 2015; 5(4):773-82. PubMed ID: 26639661
[TBL] [Abstract][Full Text] [Related]
16. The CREST-E study of creatine for Huntington disease: A randomized controlled trial.
Hersch SM; Schifitto G; Oakes D; Bredlau AL; Meyers CM; Nahin R; Rosas HD;
Neurology; 2017 Aug; 89(6):594-601. PubMed ID: 28701493
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.
Parashos SA; Swearingen CJ; Biglan KM; Bodis-Wollner I; Liang GS; Ross GW; Tilley BC; Shulman LM;
Arch Neurol; 2009 Sep; 66(9):1099-104. PubMed ID: 19597081
[TBL] [Abstract][Full Text] [Related]
18. A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.
NINDS NET-PD Investigators
Clin Neuropharmacol; 2008; 31(3):141-50. PubMed ID: 18520981
[TBL] [Abstract][Full Text] [Related]
19. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
Smith KM; Eyal E; Weintraub D;
JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
[TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
; Beal MF; Oakes D; Shoulson I; Henchcliffe C; Galpern WR; Haas R; Juncos JL; Nutt JG; Voss TS; Ravina B; Shults CM; Helles K; Snively V; Lew MF; Griebner B; Watts A; Gao S; Pourcher E; Bond L; Kompoliti K; Agarwal P; Sia C; Jog M; Cole L; Sultana M; Kurlan R; Richard I; Deeley C; Waters CH; Figueroa A; Arkun A; Brodsky M; Ondo WG; Hunter CB; Jimenez-Shahed J; Palao A; Miyasaki JM; So J; Tetrud J; Reys L; Smith K; Singer C; Blenke A; Russell DS; Cotto C; Friedman JH; Lannon M; Zhang L; Drasby E; Kumar R; Subramanian T; Ford DS; Grimes DA; Cote D; Conway J; Siderowf AD; Evatt ML; Sommerfeld B; Lieberman AN; Okun MS; Rodriguez RL; Merritt S; Swartz CL; Martin WR; King P; Stover N; Guthrie S; Watts RL; Ahmed A; Fernandez HH; Winters A; Mari Z; Dawson TM; Dunlop B; Feigin AS; Shannon B; Nirenberg MJ; Ogg M; Ellias SA; Thomas CA; Frei K; Bodis-Wollner I; Glazman S; Mayer T; Hauser RA; Pahwa R; Langhammer A; Ranawaya R; Derwent L; Sethi KD; Farrow B; Prakash R; Litvan I; Robinson A; Sahay A; Gartner M; Hinson VK; Markind S; Pelikan M; Perlmutter JS; Hartlein J; Molho E; Evans S; Adler CH; Duffy A; Lind M; Elmer L; Davis K; Spears J; Wilson S; Leehey MA; Hermanowicz N; Niswonger S; Shill HA; Obradov S; Rajput A; Cowper M; Lessig S; Song D; Fontaine D; Zadikoff C; Williams K; Blindauer KA; Bergholte J; Propsom CS; Stacy MA; Field J; Mihaila D; Chilton M; Uc EY; Sieren J; Simon DK; Kraics L; Silver A; Boyd JT; Hamill RW; Ingvoldstad C; Young J; Thomas K; Kostyk SK; Wojcieszek J; Pfeiffer RF; Panisset M; Beland M; Reich SG; Cines M; Zappala N; Rivest J; Zweig R; Lumina LP; Hilliard CL; Grill S; Kellermann M; Tuite P; Rolandelli S; Kang UJ; Young J; Rao J; Cook MM; Severt L; Boyar K
JAMA Neurol; 2014 May; 71(5):543-52. PubMed ID: 24664227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
